Continuously Infused Intracerebral (IC) Recombinant-Methionyl Human Glial Cell Line-Derived Neurotrophic Factor (r-metHuGDNF) for the Treatment of Idiopathic Parkinson's Disease Trial Phase 1 Completed June 23, 2005
Phase II Double Blind Controlled Trial of Nigral Grafting in Patients With Parkinson's Disease Trial Phase 2 Completed June 23, 2005
Randomized Study of Fetal Neurotransplantation for the Treatment of Parkinson's Disease Trial N/A Unknown June 23, 2005